Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BMY compared with ABBV: revenue, margins and what each company keeps, and the suppliers and customers both name
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BMY
Bristol Myers Squibb Co
vs
ABBV
AbbVie Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 500d
Method
›
Moved together
BMY
with
ABBV
×0.40
co-movement · ABBV on BMY · 500d
r 0.42
scale to r 0.75
Shared co-movers
8
with BMY
with ABBV
AMGN
Amgen Inc
r 0.52
r 0.50
MRK
Merck & Co., Inc.
r 0.49
r 0.49
NVS
Novartis AG
r 0.49
r 0.48
PFE
Pfizer Inc
r 0.58
r 0.48
JNJ
Johnson & Johnson
r 0.43
r 0.45
BIIB
Biogen Inc.
r 0.45
r 0.43
BMY, solid
ABBV, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
BMY
Bristol Myers Squibb Co
Change
63.03
▲
+0.87%
· post 63.14
Mkt cap
$127.7B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
ABBV
AbbVie Inc.
Change
288.78
▼
−2.07%
· post 289.89
Closed
Nov 2 '26
Mkt cap
$521.1B
Revenue
$17.0B
Q2 FY26
Revenue
$61.2B
FY25
vs
Compare
Closed
Nov 2 '26
BMY
Bristol Myers Squibb Co
vs
ABBV
AbbVie Inc.
63.03
▲
+0.87%
post 63.14
Price
288.78
▼
−2.07%
post 289.89
$127.7B
Mkt cap
$521.1B
Q3 FY26
$13.1B
Revenue
$17.0B
Q2 FY26
FY25
$48.2B
Revenue
$61.2B
FY25
Change
Change
BMY
63.03
▲
+0.87%
vs
ABBV
288.78
▼
−2.07%
Closed
Nov 2 '26